PODD
INSULET CORP
NASDAQ · Healthcare · Medical - Devices · US
$140.60
−0.67%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$141.25
From 52W high−59.41%
Volume2.49M
Market cap$9.75B
P/E (TTM)26.2x
P/S (TTM)3.2x
Div yield—
Key dataSep 18, 2026
Open
$141.25
From 52W high
−59.41%
Volume
2.49M
Market cap
$9.75B
ValuationView details →
P/E (Fwd)
20.4x
EV/EBITDA
16.0x
P/E (TTM)
26.2x
RSI (14)
46.9
MomentumView details →
1D Return
−0.67%
YTD Return
−50.07%
SummaryUpdated Jun 1, 2026
Insulet Corporation (NASDAQ:PODD) is a medical device company founded in 2000 and headquartered in Acton, Massachusetts. The company went public in 2007 and has established itself as a leading innovator in diabetes care technology. Insulet specializes in developing, manufacturing, and selling tubeless insulin delivery systems for people with insulin-dependent diabetes. The company has grown from a startup focused on revolutionizing insulin pump technology to a global leader serving over 500,000 customers worldwide, with nine consecutive years of 20%+ revenue growth through 2024.
Similar companies
Latest newsMore news →
Insulin delivery company Insulet Corp announced that board member Michael R. Minogue departed from its Board of Directors effective September 15, 2026.10d agoInsulin delivery company Insulet Corp announced that board member Timothy J. Scannell departed from its Board of Directors effective September 3, 2026, for health reasons.10d agoAlgert Global LLC increased its stake in Insulet Corporation by 75.7% during the second quarter, acquiring 62,277 additional shares, as disclosed in a 13F filing.26d ago